🔗 Share this article

A shadow economy for unlicensed slimming medications is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.

Experimental Treatment Acquiring Popularity Via Social Media

Retatrutide, which is still in clinical trials, is being advertised by online personalities for its alleged weight-reducing properties. Followers are urged to contact these profiles directly for source information, while also receiving discount codes.

Thriving Commerce on Social Networks

Additionally, a robust market exists on messaging services, where groups with thousands of members share “before and after” photos, injection guides and assertions of next-day British shipping. Vendors market the drug there before directing buyers to other platforms for transactions.

Understanding Retatrutide

This medication is an experimental injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Medical Professionals Voice Worries

However, physicians and chemists have cautions that the sale of what is still an unlicensed medication in the UK is worrisome and could result in users administering substances of uncertain source.

Some experts stated the popularity for retatrutide could be linked to the rising cost of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be promoted or supplied for human use under the British medical regulations.

Some influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still violate medicines, advertising, and customer laws, risking fines, prosecution or imprisonment.

Service Reaction and Material Removal

Based on TikTok, the service has removed violative content and prohibited related hashtags and query recommendations. The company stated it was committed to maintaining the platform secure and investing in enhancing enforcement strategies.

Digital Trading Operations

Investigations also found communities with up to nine thousand participants marketing the experimental drug using Telegram's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” instantly displays groups with thousands of users, populated with images of slimming results, glowing testimonials and detailed guides for preparing or injecting at residence.

After minutes of entering one community, a vendor posted contact information, where the majority of purchases take place. The vendor provided an instruction manual and promised shipping within 48 hours. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. None inquired about weight, medical conditions or past usage.

Product Information and Costs

Inside these communities, messages display black plastic packages with postal service stickers, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with purified liquid, or ready-to-use pens usually priced at 160 pounds for 20mg. When questioned how much time a injector should be used, sellers give conflicting responses ranging from a few weeks to “depends on your body”.

Service Moderation and Security Measures

A representative for the messaging service stated it regularly moderated harmful material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are administering materials they can’t verify. Although the science behind this drug is valid, these online versions may not contain what they claim,” said a pharmacy expert, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to current price rises for approved slimming medications such as Mounjaro. “With costs rising, patients are turning to social media. But counterfeit injections are extremely dangerous. You cannot know what’s contained or whether the conditions they were made in was clean,” she explained.

Her team has already encountered patients harmed by personal administration from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Statement

A representative from Eli Lilly said the substance was in third stage research studies and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly experimental substance not yet approved … may expose users to possibly serious medical dangers”.